RE:RE:RE:RE:RE:RE:RE:RE:Wonder what edt’s FORTUNE COOKIE Where did you see that Baxter will be getting "" half" of the revenues?
BlueJays9293 wrote: Sometimes it's crazy to me what people waste their time thinking/talking about. I've seen Spectral switch between CAD and USD all within the same Sedar filing. Talk about missing the forest for the trees. Then lately I see all this complaing about the size of the distribution agreement milestone payments. Well to these people I ask, how many tens of millions do you think Baxter is going to have to spend in marketing and commercialization in year #1 & #2 of PMX authorization???? 50mm? 75mm? 100mm? Even with FDA approval it costs a ton of money getting the word out, convincing doctors/hospitals/insurance companies and ultimately driving PMX to become the SOC as quickly as possible.
Go look at Spectral's slide # 16 again and you will see that after Baxter pays these expenses, their half of PMX revenue won't even cover these cost at a 15% penetration. Spectral has Zero cost/expenses commercializing PMX, that huge burden is completely on Baxter. Our revenue/earnings off of PMX is a pure as possible.